See the latest news and media coverage for MangoRx. We track all announcements, press releases, and industry mentions in real time, all in one place.
Telehealth platform for men's health treatments
mangorx.comLast updated
In short: MangoRx received a 180-day Nasdaq extension and entered a definitive business combination agreement with Nuclea Energy to list on Nasdaq.
(NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) today announced it has received an additional 180-calendar-day extension from the Nasdaq Stock Market (“Nasdaq”) to regain compliance with...
Transaction positions Nuclea to fund the development and commercialization of its lead-cooled, factory-built microreactor as AI and data center growth drives a generational expansion in...
Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (MGRX) ("Mangoceuticals," the "Company," or "MangoRx"), a company focused on developing, marketing, and selling health...
Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and...
Track MangoRx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to MangoRx and other trending companies.